NRx Pharmaceuticals (NRXP)
(Delayed Data from NSDQ)
$3.25 USD
+0.30 (10.17%)
Updated Sep 29, 2025 04:00 PM ET
After-Market: $3.26 +0.01 (0.31%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
NRx Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
NRXP 3.25 +0.30(10.17%)
Will NRXP be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for NRXP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NRXP
Here's Why NRx Pharmaceuticals (NRXP) Is a Great 'Buy the Bottom' Stock Now
NRx Pharmaceuticals to Post Q4 Earnings: How to Play the Stock?
NRXP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Best Momentum Stocks to Buy for January 6th
New Strong Buy Stocks for January 6th
Best Momentum Stocks to Buy for December 30th
Other News for NRXP
NRXP's Rating Maintained at 'Buy' by D. Boral Capital | NRXP Stock News
NRx Pharmaceuticals re-files abbreviated NDA for KETAFR
NRx Pharmaceuticals re-files abbreviated NDA for KETAFR
NRXP forms 20 Day Moving Average Support on September 26
NRX Pharmaceuticals Gains FDA Approval for KETAFREEā¢